Mass Device – Paulson & Co. Inc. is Boston Scientific Corp.’s largest shareholder no more, after liquidating its position in BSX completely by selling off some 15 million shares of the Natick, Mass.-based medical device company during the second quarter. The New York-based fund has been steadily selling off its BSX shares for more than a year. As of the end of the first quarter 2011, the fund held 15 million shares, which was valued at $107.9 million at the time, according to regulatory filings.
However, the fund sold off its remaining holdings sometime during the second quarter, when BSX share prices ranged from $7.19 March 31 to $6.91 by June 30. That leaves Paulson fetching between $104 million and $108 million with the sell-off.
